425.40
-15.25 (-3.46%)
-15.25 (-3.46%)
Upgrade to Real-Time
Afterhours (Closed)
Low
63.64
High
497.17
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -15.25 | -3.46% | 425.40 | 19:59:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 438.76 | 406.90 | 442.00 | 430.05 | 440.65 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 425.35 | 426.00 | 0.65 | 1 | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 351,123 | 30,523,117 | $ 423.84 | $ 12,937,049,464 | - | 63.64 - 497.17 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:59 | 10 | $ 426.00 | USD |
Period:
Draw Mode:
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 171.71B | 403.65M | 295.52M | $ 803.40M | $ 400.01M | -1.95 | 54.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -674.27k | 5.80% |
Moderna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 462.59 | 464.85 | 406.8704 | 433.25 | 13,177,872 | -37.19 | -8.04% |
| 1 Month | 374.63 | 464.85 | 362.8001 | 412.88 | 13,443,580 | 50.77 | 13.55% |
| 3 Months | 221.26 | 497.17 | 214.07 | 364.12 | 18,580,654 | 204.14 | 92.26% |
| 6 Months | 150.24 | 497.17 | 117.3411 | 290.91 | 13,488,876 | 275.16 | 183.15% |
| 1 Year | 68.53 | 497.17 | 63.64 | 201.32 | 14,955,136 | 356.87 | 520.75% |
| 3 Years | 22.00 | 497.17 | 11.54 | 127.88 | 10,620,482 | 403.40 | 1,833.64% |
| 5 Years | 22.00 | 497.17 | 11.54 | 127.88 | 10,620,482 | 403.40 | 1,833.64% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
